Posts

Understanding the Four Main Types of Lupus: The Role of Interleukins, Immune Dysregulation, and Emerging Therapeutic Approaches

By
Introduction Lupus is a complex autoimmune condition in which the immune system mistakenly attacks the body's own healthy tissues. Depending on the form of lupus, this immune response can affect the skin, joints, kidneys, blood vessels, nervous system, heart, lungs, and other organs. Major health organizations, including the Lupus Foundation of America and the Centers for Disease Control and Prevention (CDC), recognize four main types of lupus: systemic lupus erythematosus (SLE), cutaneous lupus erythematosus (CLE), drug-induced lupus, and neonatal lupus. Although these conditions share certain immune-related characteristics, they differ in their clinical manifestations, underlying mechanisms, and treatment approaches. One important area of scientific research involves interleukins (ILs) , a family of immune-signaling proteins that regulate inflammation, immune-cell communication, and autoimmune activity. Researchers are investigating how abnormal interleukin signaling contributes ...
Post a Comment
Read more

Psoriasis, Psoriatic Arthritis, IL-23 and Skyrizi: Understanding Chronic Inflammation and Targeted Biological Therapy

By
The role of the IL-23/IL-17 inflammatory pathway in psoriasis, psoriatic arthritis and related immune-mediated diseases, and how Skyrizi (risankizumab) helps control chronic inflammation. Introduction: Chronic Inflammation as a Common Biological Link Psoriasis and psoriatic arthritis are systemic immune-mediated inflammatory diseases that extend beyond the skin and joints. Both involve dysregulation of the immune system, with inflammatory signaling molecules known as cytokines playing important roles in maintaining chronic inflammation. Among these cytokines, interleukin-23 (IL-23) and interleukin-17 (IL-17) are particularly important in the development and progression of psoriatic disease. The IL-23/IL-17 signaling pathway regulates immune-cell activity and inflammatory responses. When dysregulated, it contributes to persistent inflammation, tissue injury and structural changes in affected organs. The development of targeted biological therapies has significantly changed the treatment...
Post a Comment
Read more

Phospholipids and Antiphospholipid Syndrome (APS): The Connection Between the Brain, Skin, and Vascular System

By
Understanding how essential membrane lipids support neurological function, vascular integrity, and skin health—and how autoimmune antibodies in APS can disrupt these systems.   Introduction Phospholipids are essential components of nearly every cell in the human body. They provide the structural foundation of biological membranes and participate in cellular communication, lipid transport, inflammation, and neurological function. Their importance is particularly evident in the brain, skin, and vascular system, where normal cellular function depends on the integrity of membranes and the complex signaling processes associated with them. Antiphospholipid syndrome (APS) is an autoimmune disorder characterized by persistent antiphospholipid antibodies (aPL) associated with an increased risk of abnormal blood clotting. Despite its name, APS does not simply involve antibodies attacking all phospholipids. Instead, many clinically important antibodies recognize phospholipid-binding proteins,...
Post a Comment
Read more